Element Capital Management LLC Mannkind Corp Transaction History

Element Capital Management LLC

  • $2.17 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$1.59 - $2.38 $200,403 - $299,975
-126,040 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$2.28 - $3.8 $287,371 - $478,952
126,040 New
126,040 $287,000
Q4 2017

Feb 14, 2018
SELL
$2.28 - $6.71 $368,997 - $1.09 Million
-161,841 Closed
0 $0
Q3 2017

Nov 13, 2017
SELL
$1.15 - $2.29 $115,113 - $229,226
-100,099 Reduced 38.21%
161,841 $351,000
Q2 2017

Aug 14, 2017
BUY
N/A
261,940
261,940 $369,000

Others Institutions Holding MNKD

# of Institutions
243
Shares Held
148M
Call Options Held
1.62M
Put Options Held
802K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email